Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

161.50
-7.0200-4.17%
Post-market: 160.68-0.8229-0.51%19:51 EDT
Volume:1.82M
Turnover:296.64M
Market Cap:21.67B
PE:-46.09
High:169.60
Open:166.35
Low:160.23
Close:168.52
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.03
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-97.24
PE(LYR):-48.64

Loading ...

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Reuters
·
Aug 11

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.
·
Aug 10

Guardant Health (GH) Following Earnings And Higher Guidance Has Valuation Back In Focus

Simply Wall St.
·
Aug 08

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Movement Alert|Guardant Health Inc. Rises 5.39% in Regular Trading, Q2 Revenue Beat and Full-Year Guidance Raise Extend Post-Earnings Momentum

Market Focus
·
Aug 07

GH Research is Maintained at Buy by Needham

Dow Jones
·
Aug 07

GH Research price target raised to $39 from $32 at Needham

TIPRANKS
·
Aug 07

GH Research reports Q2 EPS (23c), consensus (30c)

TIPRANKS
·
Aug 06

GH Research Q2 EPS $(0.23) Beats $(0.30) Estimate

Benzinga Earnings
·
Aug 06

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Reuters
·
Aug 06

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 04

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.
·
Aug 04

Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)

TIPRANKS
·
Aug 03

Guardant Health Shares Climb Following Outlook Raise

Dow Jones
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 10.72% in Regular Trading, Q2 Revenue Significantly Beats Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 31

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Guardant Health is Maintained at Buy by BTIG

Dow Jones
·
Jul 31

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS
·
Jul 31